Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3341)
All Articles published online
|
Oct 7, 2009 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hsieh PM, Hung KC, Chen YS. Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: Case reports and literature review. World J Gastroenterol 2009; 15(37): 4726-4728 [PMID: 19787837 DOI: 10.3748/wjg.15.4726] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i37/4726.htm |
| Number | Citing Articles |
| 1 |
Ho Hung Cheung, Wong Hoi She, Desmond Y.H. Yap, Simon H.Y. Tsang, Tan To Cheung. A case report of tumor lysis syndrome after stage-one ALPPS. Medicine 2022; 101(10): e29040 doi: 10.1097/MD.0000000000029040
|
| 2 |
Janja Tarčuković, Lara Valenčić, Željka Polonijo, Ana Fućak, Boban Dangubić, Igor Grubješić. Acute Liver Failure as the Leading Manifestation of Spontaneous Tumour Lysis Syndrome in a Patient with NonHodgkin Lymphoma: Do Current Diagnostic Criteria of Tumour Lysis Syndrome Need Re-Evaluation?. Case Reports in Critical Care 2019; 2019: 1 doi: 10.1155/2019/2358562
|
| 3 |
Tsai-Hung Yen, Chung-Hsin Chang, Sz-Iuan Shiu. Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma. Case Reports in Gastroenterology 2020; 14(2): 367 doi: 10.1159/000508583
|
| 4 |
Dalia H. Abou-Elela, Eman Abdel Sameea, Tamer Fakhry. Assessment of the diagnostic role of annexin A2 (ANXA2) and insulin-like growth factor-1 as serum markers for hepatocellular carcinoma. Egyptian Liver Journal 2016; 6(1): 1 doi: 10.1097/01.ELX.0000481901.80695.e7
|
| 5 |
Diana Katiman, Jeeta Manikam, Khean-Lee Goh, Basri Johan Abdullah, Sanjiv Mahadeva. Tumour Lysis Syndrome: a Rare Complication of Trans-Arterial Chemo-Embolisation with Doxorubicin Beads for Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2012; 43(S1): 187 doi: 10.1007/s12029-012-9373-6
|
| 6 |
Peter Huppert, Nikolas Kortes, Clemens Kratochwil, Boris Radeleff, Anne Schmitz, Ulrike Stampfl. Angiofibel. 2021; : 409 doi: 10.1007/978-3-662-56243-7_14
|
| 7 |
Masashi Fujita, Ken Okai, Manabu Hayashi, Kazumichi Abe, Atsushi Takahashi, Takashi Kimura, Akira Kenjo, Shigeru Marubashi, Yuko Hashimoto, Hiromasa Ohira. Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization. Internal Medicine 2019; 58(8): 1103 doi: 10.2169/internalmedicine.1214-18
|
| 8 |
EIMAN ALEEM, AYMAN ELSHAYEB, NIHAL ELHABACHI, AMAL REFAAT MANSOUR, AHMED GOWILY, ASMAA HELA. Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncology Letters 2012; 3(3): 704 doi: 10.3892/ol.2011.546
|
| 9 |
Yuan-Hao Lo, Ming-Tsun Tsai, Chen-Yu Kuo, Wen-Sheng Liu, Rheun-Chuan Lee, Yi-Chen Yeh, Chung-Pin Li, Jinn-Yang Chen, Yee Chao. Transcatheter arterial embolization with trisacryl gelatin microspheres (Embosphere®) leads to life-threatening tumor lysis syndrome in a rectal carcinoid patient with hepatic metastases. Acta Radiologica Short Reports 2012; 1(10): 1 doi: 10.1258/arsr.2012.110011
|
| 10 |
Belal M. Firwana, Rim Hasan, Nour Hasan, Fares Alahdab, Iyad Alnahhas, Seba Hasan, Joseph Varon. Tumor Lysis Syndrome: A Systematic Review of Case Series and Case Reports. Postgraduate Medicine 2012; 124(2): 92 doi: 10.3810/pgm.2012.03.2540
|
| 11 |
Shin Young Kim, Hee Yeon Kim, Yu Seung Kim, Sang Min Lee, Chang Wook Kim. Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma. Yeungnam University Journal of Medicine 2015; 32(1): 47 doi: 10.12701/yujm.2015.32.1.47
|
| 12 |
Karen P. Seiter, Nicholas J. Sarlis, Edward S. Kim. Management of hyperuricemia in adults with or at risk of tumor lysis syndrome. Community Oncology 2011; 8(4): 163 doi: 10.1016/S1548-5315(12)70067-0
|
| 13 |
Fumi Taira, Yoshiya Horimoto, Mitsue Saito. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Breast Cancer 2015; 22(6): 664 doi: 10.1007/s12282-013-0448-4
|
| 14 |
Hsaing-Hung Lin, Wei-Ho Chang, Horng-Yuan Wang, Ming-Jen Chen, Shou-Chuan Shih. Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient. International Journal of Gerontology 2014; 8(3): 171 doi: 10.1016/j.ijge.2014.03.005
|
| 15 |
Tongchun Xue, Fan Le, Rongxin Chen, Xiaoying Xie, Lan Zhang, Ningling Ge, Yi Chen, Yanhong Wang, Boheng Zhang, Shenglong Ye, Zhenggang Ren. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study. Medical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0504-3
|
| 16 |
Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient. Clinical and Molecular Hepatology 2015; 21(1): 85 doi: 10.3350/cmh.2015.21.1.85
|
| 17 |
Gabriela Lupușoru, Ioana Ailincăi, Georgiana Frățilă, Oana Ungureanu, Andreea Andronesi, Mircea Lupușoru, Mihaela Banu, Ileana Văcăroiu, Constantin Dina, Ioanel Sinescu. Tumor Lysis Syndrome: An Endless Challenge in Onco-Nephrology. Biomedicines 2022; 10(5): 1012 doi: 10.3390/biomedicines10051012
|
| 18 |
Nearmeen M. Rashad, Amal S. El-Shal, Eman H. Abd Elbary, Mohamed H. Abo Warda, Osama Hegazy. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma. Cytokine 2014; 68(1): 50 doi: 10.1016/j.cyto.2014.02.006
|
| 19 |
Hiroki Higashihara, Yusuke Ono, Kaisyu Tanaka, Kosuke Tomotake, Noriyuki Tomiyama. Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan. International Journal of Gastrointestinal Intervention 2021; 10(4): 152 doi: 10.18528/ijgii210042
|
| 20 |
Ping-Hung Liu, Jin-Wen Hsu, Wen-Ching Kung, Yu-Chiuan Wu, Wen-Yen Chang, Chun-Ming Su. Tumor Lysis Syndrome Occurring After Transarterial Embolization in a 70-year-old Man with a Hepatocellular Carcinoma Ruptured in a Motor Vehicle Accident. International Journal of Gerontology 2014; 8(2): 100 doi: 10.1016/j.ijge.2013.03.014
|
| 21 |
Eiman Aleem, Dirk Nehrbass, Fritz Klimek, Doris Mayer, Peter Bannasch. Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis. Toxicologic Pathology 2011; 39(3): 524 doi: 10.1177/0192623310396905
|
| 22 |
Wan-Ling Tsai, Po-Chin Liang, Chien-Hung Chen. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma. Journal of the Formosan Medical Association 2012; 111(12): 724 doi: 10.1016/j.jfma.2011.12.009
|
| 23 |
Yuhi Sakamoto, Keizo Kato, Hiroshi Abe, Takeshi Yonezawa, Sadahiro Ito, Makiko Ika, Kiichiro Yoza, Mamika Ohara, Shogo Sakasai, Shohei Shimizu, Shinji Endo. A case of hepatocellular carcinoma caused severe tumor lysis by ramucirumab. Kanzo 2021; 62(3): 129 doi: 10.2957/kanzo.62.129
|
| 24 |
Riyadh M Alqurashi , Husam H Tamim, Ziyad D Alsubhi, Alyazid A Alzahrani, Emad Tashkandi. Tumor Lysis Syndrome in Patients With Solid Tumors: A Systematic Review of Reported Cases. Cureus 2022; doi: 10.7759/cureus.30652
|
| 25 |
Shiro Miyayama, Osamu Matsui. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome. Journal of Vascular and Interventional Radiology 2016; 27(9): 1269 doi: 10.1016/j.jvir.2016.04.014
|
| 26 |
Danica Maria Vodopivec, Jose Enrique Rubio, Alessia Fornoni, Oliver Lenz. An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review. Case Reports in Medicine 2012; 2012: 1 doi: 10.1155/2012/468452
|
| 27 |
Hiroki Higashihara, Yasushi Kimura, Yusuke Ono, Kaishu Tanaka, Noriyuki Tomiyama. Effective Utilization of Conventional Transarterial Chemoembolization and Drug-eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma: A Guide to Proper Usage. Interventional Radiology 2023; doi: 10.22575/interventionalradiology.2023-0009
|
| 28 |
Nicole Saddic Thomas, Gail Kerr, Debra Benator, Jack H. Lichy. A Patient With Hepatitis C Virus Infection and Inflammatory Polyarthritis. Arthritis Care & Research 2013; 65(11): 1885 doi: 10.1002/acr.22075
|
| 29 |
Jen-Wei Chou, Ken-Sheng Cheng, Trupti Akella, Chi Chan Lee, Teressa Ju. Tumor Lysis Syndrome in Patients With Hepatocellular Carcinoma: A Systematic Review of Published Case Reports
. Cureus 2021; doi: 10.7759/cureus.19128
|
| 30 |
Aibek E. Mirrakhimov, Alaa M. Ali, Maliha Khan, Aram Barbaryan. Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature. Rare Tumors 2014; 6(2): 68 doi: 10.4081/rt.2014.5389
|
| 31 |
M. Criscuolo, L. Fianchi, G. Dragonetti, L. Pagano. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency. Expert Review of Hematology 2016; 9(2): 197 doi: 10.1586/17474086.2016.1127156
|
| 32 |
Zhong Ye, Juan P Palazzo, Liz Lin, Yinzhi Lai, Fran Guiles, Ronald E Myers, Jin Han, Jinliang Xing, Hushan Yang. Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients. Journal of Gastroenterology and Hepatology 2013; 28(9): 1469 doi: 10.1111/jgh.12237
|
| 33 |
Vikash Kumar, Mili Shah, Dhir Gala, Manmeet K Singh, Herby Jeanty, Reeny Thomas, Arnold N Forlemu, Vijay Reddy Gayam, Denzil Etienne. Hepatic Dystrophic Calcification Secondary to Transarterial Chemoembolization: Case Report and Review of Literature. Cureus 2023; doi: 10.7759/cureus.35765
|
| 34 |
Kang Zheng, Johan M. Kros, Jin Li, Ping-Pin Zheng. DNA-nanorobot-guided thrombin-inducing tumor infarction: raising new potential clinical concerns. Drug Discovery Today 2020; 25(6): 951 doi: 10.1016/j.drudis.2020.03.005
|